RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease
出版年份 2019 全文链接
标题
RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease
作者
关键词
-
出版物
International Journal of Endocrinology
Volume 2019, Issue -, Pages 1-11
出版商
Hindawi Limited
发表日期
2019-09-19
DOI
10.1155/2019/2151302
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
- (2018) Varman T. Samuel et al. Cell Metabolism
- Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography
- (2018) Eugenia Tsai et al. Clinics in Liver Disease
- New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
- (2018) Nahum Mendez-Sanchez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults
- (2018) Susana A. Palma-Duran et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)
- (2018) Rohini Mehta et al. PLoS One
- Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma—a composite scenario
- (2018) Luca Viganò et al. HEPATOBILIARY SURGERY AND NUTRITION
- Adipose Tissue Derived Free Fatty Acids Initiate Myeloid Cell Accumulation in Mouse Liver in States of Lipid Oversupply
- (2018) Daniel B. Harmon et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Letter to the Editor: “Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men”
- (2018) Kamyar Asadipooya JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
- (2017) Elizabeth M Brunt et al. GUT
- Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran
- (2017) Behnam Honarvar et al. Hepatitis Monthly
- Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease
- (2017) Jeffrey B. Schwimmer et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Glyoxal toxicity in isolated rat liver mitochondria
- (2017) M Goudarzi et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
- (2017) Paola Dongiovanni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver
- (2017) Anja Petrović et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Pathology of non-alcoholic fatty liver disease
- (2017) Pierre Bedossa LIVER INTERNATIONAL
- The epidemiology of non-alcoholic fatty liver disease
- (2017) Stefano Bellentani LIVER INTERNATIONAL
- Non-alcoholic fatty liver disease: A sign of systemic disease
- (2017) Isabella Reccia et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice
- (2017) Peicheng Li et al. Molecular Medicine Reports
- Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
- (2017) Giovanni Targher et al. Nature Reviews Nephrology
- Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
- (2017) Kyunghee Byun et al. PHARMACOLOGY & THERAPEUTICS
- Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma
- (2017) Dan-Vinh Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity
- (2017) James J. DiNicolantonio et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
- (2017) Ahad Eshraghian WORLD JOURNAL OF GASTROENTEROLOGY
- Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
- (2017) Masayoshi Takeuchi et al. Nutrients
- Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
- (2017) Laura Antonucci et al. Nutrients
- Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease
- (2017) Manuela Aragno et al. Nutrients
- Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis
- (2017) Gloria Brusotti et al. Scientific Reports
- Blocking AGE-RAGE Signaling Improved Functional Disorders of Macrophages in Diabetic Wound
- (2017) Qi Wang et al. Journal of Diabetes Research
- Increased liver AGEs induce hepatic injury mediated through an OST48 pathway
- (2017) Aowen Zhuang et al. Scientific Reports
- Diaphanous-related formin 1 as a target for tumor therapy
- (2016) Yuan-Na Lin et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Cellular mechanisms and consequences of glycation in atherosclerosis and obesity
- (2016) Raquel López- Díez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values
- (2016) Salvatore Petta et al. HEPATOLOGY
- Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes
- (2016) Jian Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol
- (2016) Lei Xu et al. Lipids in Health and Disease
- Fatty acid synthesis configures the plasma membrane for inflammation in diabetes
- (2016) Xiaochao Wei et al. NATURE
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
- (2016) Christopher Leung et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
- (2016) Michaele B. Manigrasso et al. Scientific Reports
- Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
- (2016) Zhong’e Zhou et al. Journal of Diabetes Research
- Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway
- (2015) Qian Wu et al. APOPTOSIS
- AGEs Induce Apoptosis in Rat Osteoblast Cells by Activating the Caspase-3 Signaling Pathway Under a High-Glucose Environment In Vitro
- (2015) Jiaqiang Liu et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction
- (2015) Sook Hee Ku et al. ARCHIVES OF PHARMACAL RESEARCH
- Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway
- (2015) EMS Litwinoff et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
- (2015) Shih-Chi Su et al. MEDICINE
- Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome
- (2015) Francesca Santilli et al. VASCULAR PHARMACOLOGY
- Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus
- (2015) Subrata Kumar Biswas et al. Journal of Diabetes Research
- Association of 2184AG Polymorphism in the RAGE Gene with Diabetic Nephropathy in Chinese Patients with Type 2 Diabetes
- (2015) Wei Cai et al. Journal of Diabetes Research
- RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
- (2014) Fei Song et al. DIABETES
- Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma
- (2014) Hiromi Kan et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 在晚期糖基化终末产物环境中细胞外基质通过RAGE受体依赖性途径调节，转化生长因子-β1可以促进这种调节
- (2014) Andreea Iren Serban et al. Journal of Diabetes
- Role of advanced glycation end products in cellular signaling
- (2014) Christiane Ott et al. Redox Biology
- Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study
- (2013) Kamran Bagheri Lankarani et al. Hepatitis Monthly
- RAGE regulation and signaling in inflammation and beyond
- (2013) Katrin Kierdorf et al. JOURNAL OF LEUKOCYTE BIOLOGY
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
- (2013) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E
- (2012) E. D’Adamo et al. FREE RADICAL RESEARCH
- Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy
- (2012) Peipei Kang et al. GENE
- The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity
- (2012) J M Brix et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of Dietary Advanced Glycation End Products on Mouse Liver
- (2012) Raza Patel et al. PLoS One
- Elevated Serum Levels of Advanced Glycation End Products and their Monocyte Receptors in Patients with Type 2 Diabetes
- (2011) Xu-dong Su et al. ARCHIVES OF MEDICAL RESEARCH
- Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells
- (2011) Mei He et al. EMBO REPORTS
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
- (2011) Ruben Hernaez et al. HEPATOLOGY
- Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis
- (2011) Katrien H.J. Gaens et al. JOURNAL OF HEPATOLOGY
- What Is the Significance of Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products in Liver Steatosis in Obese Prepubertal Children?
- (2010) Ebe D'Adamo et al. ANTIOXIDANTS & REDOX SIGNALING
- Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
- (2010) Yuki Kimura et al. JOURNAL OF GASTROENTEROLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
- (2009) Yusuf Yilmaz et al. CLINICAL BIOCHEMISTRY
- Advanced Glycation End Products and Insulin Resistance
- (2008) Hiroyuki Unoki et al. CURRENT PHARMACEUTICAL DESIGN
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
- (2008) Barry I. Hudson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant α-lipoic acid on insulin resistance in the obese Zucker rat
- (2008) Elizabeth A. Muellenbach et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population
- (2008) Giuseppe Danilo Norata et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started